Why do some breast cancers become treatment-resistant?

Dr. Brown and his colleagues believe that by putting two and two together, as it were, through the combined findings of all these studies led by the Dana-Farber Cancer Institute, specialists may be able to devise effective treatments for ER-positive breast cancers that don’t respond to endocrine therapy alone. “These results support the potential of this combination as a therapeutic strategy to overcome endocrine resistance caused by the ER mutants,” the researchers suggest.

Breast cancer treatments may increase the risk of heart disease 

Breast cancer patients may be at an increased risk of cardiovascular diseases including heart failure and may benefit from a treatment approach that weighs the benefits of specific therapies against potential damage to the heart, according to a new scientific statement from the American Heart Association published in its journal Circulation.

Oncolytic Virus Therapy: Using Tumor-Targeting Viruses to Treat Cancer

Since the late 1800s, doctors have observed that some patients with cancer go into remission, if only temporarily, after a viral infection. Today, several dozen viruses—and a few strains of bacteria—are being studied as potential cancer treatments, according to research presented at an NCI-sponsored conference on using microbes as cancer therapies in 2017. “Oncolytic virus therapy is of growing interest to researchers for one reason: It’s working,” said Juan Fueyo, M.D., of the University of Texas MD Anderson Cancer Center, who co-developed a type of oncolytic virus being tested in patients with brain tumors.

Common Antimicrobial in Toothpaste Linked to Inflammation and Cancer

The antimicrobial chemical triclosan is in thousands of products that we use daily: hand soaps, toothpastes, body wash, kitchenware and even some toys. Work in our lab suggests that this compound may have widespread health risks, including aggravating inflammation in the gut and promoting the development of colon cancer by altering the gut microbiota, the community of microbes found in our intestines.

Best Metastatic Breast Cancer Blogs 2018 

Well, these blogs get it. You’ll find no pity parties here. Instead, you’ll find a collective group of women who often get straight to the nitty-gritty: post-mastectomy life, treatment side effects, breast cancer symptoms, and how to tell your children. You’ll also get plenty of advice on how to manage the disease, from making your bucket list to using alternative therapies like painting to de-stress.

After a Cancer Diagnosis Comes the ‘Staging’

After a diagnosis is made, your doctor will stage the cancer. The stage defines the location of the cancer, how much it has spread, how big it is, and how aggressive it is. Knowing the stage of cancer is important because it typically determines your treatment options.

Talking About Medical Marijuana

THE MAJORITY—AROUND 80 PERCENT—OF MEDICAL ONCOLOGISTS said they discuss medical marijuana with patients, according to a study published May 10 in the Journal of Clinical Oncology based on a survey of U.S. oncologists. Nearly half said they had recommended medical marijuana clinically in the past year. But despite this openness, around 70 percent of medical oncologists reported they don’t feel they know enough to make recommendations surrounding medical marijuana use.

Cancer ‘vaccine’ eliminates all traces of cancer in mice

Injecting minute amounts of two immune-stimulating agents directly into solid tumors in mice was able to eliminate all traces of cancer in the animals — including distant, untreated metastases (spreading cancer locations), according to a study by Stanford University School of Medicine researchers. The researchers believe this new “in situ vaccination” method could serve as a rapid and relatively inexpensive cancer therapy — one that is unlikely to cause the adverse side effects often seen with bodywide immune stimulation.

Most Women with Early-Stage Breast Cancer Don’t Need Chemo 

Thanks to the long-awaited results of a large, NIH-funded clinical trial, we know that about 70 percent of women with hormone receptor (HR)-positive, HER2-negative, axillary lymph node-negative breast cancer—including those with mid-range scores on the cancer recurrence scale—do not benefit from chemotherapy [1]. These findings promise to spare a great many women with breast cancer from unnecessary exposure to costly and potentially toxic chemotherapy.